Tivic Health Systems Inc

NASDAQ:TIVCUnited States

NASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)

Other current liabilities -- 193 -------------- -------------- TOTAL CURRENT LIABILITIES 560 1,401 TOTAL LONG-TERM LIABILITIES -- 176 STOCKHOLDERS' EQUITY Common stock 1 -- Additional paid in capital 44,897 41,466 Accumulated deficit (42,064) (37,886) -------------- -------------- TOTAL STOCKHOLDERS' EQUITY 2,834 3,580 -------------- -------------- TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 3,394 $ 5,157 ============== ============== Tivic Health Systems, Inc. Condensed Statements of Operations (in thousands, except share and per share data) ---------------------------------------------------------------------- Three Months Ended September 30, Nine Months Ended 2024 2023 2024 2023 ----------- ----------- ----------- ----------- REVENUES $ 126 $ 282 $ 600 $ 819 COST OF SALES 82 174 359 537 --------- --------- --------- ------- GROSS PROFIT 44 108 241 282 OPERATING EXPENSES Research and development 422 337 980 1,295 Sales and marketing 234 480 946 1,390 General and administrative 819 1,051 2,433 3,598 --------- --------- --------- ------- TOTAL OPERATING EXPENSES 1,475 1,868 4,359 6,283 --------- --------- --------- ------- NET OPERATING LOSS (1,431) (1,760) (4,118) (6,001) OTHER EXPENSE -- -- 60 -- --------- --------- --------- ------- NET LOSS $ (1,431) $ (1,760) $ (4,178) $ (6,001) ========= ========= ========= ======= NET LOSS PER SHARE - BASIC AND DILUTED $ (0.23) $ (1.48) $ (1.07) $ (10.60) WEIGHTED-AVERAGE NUMBER OF SHARES - BASIC AND DILUTED 6,191,127 1,189,821 3,897,938 566,228

Other current liabilities -- 193 -------------- -------------- TOTAL CURRENT LIABILITIES 560 1,401 TOTAL LONG-TERM LIABILITIES -- 176 STOCKHOLDERS' EQUITY Common stock 1 -- Additional paid in capital 44,897 41,466 Accumulated deficit (42,064) (37,886) -------------- -------------- TOTAL STOCKHOLDERS' EQUITY 2,834 3,580 -------------- -------------- TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 3,394 $ 5,157 ============== ============== Tivic Health Systems, Inc. Condensed Statements of Operations (in thousands, except share and per share data) ---------------------------------------------------------------------- Three Months Ended September 30, Nine Months Ended 2024 2023 2024 2023 ----------- ----------- ----------- ----------- REVENUES $ 126 $ 282 $ 600 $ 819 COST OF SALES 82 174 359 537 --------- --------- --------- ------- GROSS PROFIT 44 108 241 282 OPERATING EXPENSES Research and development 422 337 980 1,295 Sales and marketing 234 480 946 1,390 General and administrative 819 1,051 2,433 3,598 --------- --------- --------- ------- TOTAL OPERATING EXPENSES 1,475 1,868 4,359 6,283 --------- --------- --------- ------- NET OPERATING LOSS (1,431) (1,760) (4,118) (6,001) OTHER EXPENSE -- -- 60 -- --------- --------- --------- ------- NET LOSS $ (1,431) $ (1,760) $ (4,178) $ (6,001) ========= ========= ========= ======= NET LOSS PER SHARE - BASIC AND DILUTED $ (0.23) $ (1.48) $ (1.07) $ (10.60) WEIGHTED-AVERAGE NUMBER OF SHARES - BASIC AND DILUTED 6,191,127 1,189,821 3,897,938 566,228